Cilazapril Monohydrate

HCID 56329

Grundinformationen

CAS
92077-78-6
Standard-SMILES
CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O.O
InChIKey
JQRZBPFGBRIWSN-YOTVLOEGSA-N
Summenformel
C22H33N3O6
Durchschnittliche Molmasse
435,5 g/mol
Monoisotopische Masse
435,23693578

Überblick

Cilazapril monohydrate is a hydrate that is the monohydrate of cilazapril. It is used for the treatment of hypertension and heart failure. It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor, an antihypertensive agent and a prodrug. It contains a cilazapril.

Namen und Bezeichner

Bevorzugter Name
Cilazapril Monohydrate
IUPAC
(4S,7S)-7-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid;hydrate
Englischer Name
Cilazapril Monohydrate
Summenformel
C22H31N3O5.H2O
Molmasse
435.51

Namen und Synonyme

CILAZAPRIL MONOHYDRATE92077-78-6Ro 31-2848 monohydrateCilazapril hydrateCHEBI:145568DTXSID00238846(1S,9S)-9-(((S)-1-Carboxy-3-phenylpropyl)amino)octahydro-10-oxo-6H-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid 9-ethyl ester monohydrate(1S,9S)-9-[[(S)-1-Carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid 9-ethyl ester monohydrateRefChem:918623DTXCID50161337(1S,9S)-9-((1S)-(1-Ethoxycarbonyl-3-phenylpropyl)amino)-10-oxooctahydro-6H-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid monohydrateCilazapril (monohydrate)
Weitere Namen anzeigen
JustorDynormVascaseInitissInhibaceCilazapril CRSCILAZAPRIL EPC(Vascace monohydrateInhibace monohydrate
Cilazapril (USAN)(4S,7S)-7-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid;hydrateInhibace (TN)CILAZAPRIL [USAN](1S,9S)-9-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid hydrate(1S,9S)-9-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid--water (1/1)MFCD00865788Cilazapril [USAN:INN:BAN:JAN]

Datenbank-Bezeichner

CAS
92077-78-6
PubChem CID
56329
DTXSID
DTXSID00238846
ChEBI
CHEBI:145568
UNII
19KW7PI29F
EC Number
620-542-7

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
100 Ų
H-Brücken-Donoren
3
H-Brücken-Akzeptoren
8
Frei drehbare Bindungen
9
Schwere Atome
31

Physikochemische Eigenschaften

Schmelzpunkt
98 ° · 98° (dec)
storage temp.
-20 °C · Store at -20°C
Löslichkeit
Slightly soluble in water, freely soluble in methanol and in methylene chloride.
Aggregatzustand
Solid
pka
1 · pKa1 3.3; pKa2 6.4(at 25℃)
Farbe
White to off-white

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

P203, P280, P318, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 2 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Hazard Classes and CategoriesRepr. 2 (100%)

Sicherheitsdaten

Alarmwort
Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H361

Chemie und Industrie

Pharmakologische Informationen

MeSH Pharmacological Classification · 2 Einträge

A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Anwendungen · 2 Einträge

BeschreibungCilazapril is a new ACE inhibitor useful in the management of mild to moderate hypertension. Orally administered cilazapril is a prodrug which is de-esterified to its active diacid metabolite cilazprilat. Compared with enalapril and captopril, cilazapril is more potent and longer lasting.

VerwendenAntihypertensive.

Vor- und nachgelagerte Produkte

Anbieter45 Anbieter

陕西缔都新材料有限公司81124267 17392282731 · [email protected]
成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
Aladdin Scientific[email protected]

Zugehörige Reaktionen

2

Notizen zur Verbindung

Wird geladen…